These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 32779503

  • 21. Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.
    Yang A, Yu Q, Ju H, Song L, Kou X, Shen R.
    Chem Biodivers; 2020 Oct; 17(10):e2000442. PubMed ID: 32692899
    [Abstract] [Full Text] [Related]

  • 22. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP, Shankar G, Jahan S, Singh G, Kumar N, Barik A, Upadhyay P, Singh L, Kamble K, Singh GK, Tiwari S, Garg P, Gupta S, Modi G.
    Bioorg Med Chem; 2021 Sep 15; 46():116385. PubMed ID: 34481338
    [Abstract] [Full Text] [Related]

  • 23. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B, Gulcan HO, Aksakal F, Ercetin T, Oruklu N, Umit Bagriacik E, Dogruer DS.
    Bioorg Chem; 2018 Sep 15; 79():235-249. PubMed ID: 29775949
    [Abstract] [Full Text] [Related]

  • 24. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Tripathi A, Choubey PK, Sharma P, Seth A, Saraf P, Shrivastava SK.
    Bioorg Chem; 2020 Jan 15; 95():103506. PubMed ID: 31887472
    [Abstract] [Full Text] [Related]

  • 25. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M, Chehardoli G, Bahiraei M, Akbarzadeh T, Ranjbar A, Rastegari A, Najafi Z.
    Mol Divers; 2022 Feb 15; 26(1):489-503. PubMed ID: 34491490
    [Abstract] [Full Text] [Related]

  • 26. Design and Synthesis of Novel Arylisoxazole-Chromenone Carboxamides: Investigation of Biological Activities Associated with Alzheimer's Disease.
    Saeedi M, Rastegari A, Hariri R, Mirfazli SS, Mahdavi M, Edraki N, Firuzi O, Akbarzadeh T.
    Chem Biodivers; 2020 May 15; 17(5):e1900746. PubMed ID: 32154628
    [Abstract] [Full Text] [Related]

  • 27. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity.
    Vafadarnejad F, Mahdavi M, Karimpour-Razkenari E, Edraki N, Sameem B, Khanavi M, Saeedi M, Akbarzadeh T.
    Bioorg Chem; 2018 Apr 15; 77():311-319. PubMed ID: 29421707
    [Abstract] [Full Text] [Related]

  • 28. Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
    Parlar S, Sayar G, Tarikogullari AH, Karadagli SS, Alptuzun V, Erciyas E, Holzgrabe U.
    Bioorg Chem; 2019 Jun 15; 87():888-900. PubMed ID: 30538051
    [Abstract] [Full Text] [Related]

  • 29. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
    Amin KM, Abdel Rahman DE, Abdelrasheed Allam H, El-Zoheiry HH.
    Bioorg Chem; 2021 May 15; 110():104792. PubMed ID: 33799178
    [Abstract] [Full Text] [Related]

  • 30. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q, Li Y, Cao Z, Qiang X, Tan Z, Deng Y.
    Bioorg Chem; 2019 Mar 15; 84():137-149. PubMed ID: 30500523
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors.
    Arab S, Sadat-Ebrahimi SE, Mohammadi-Khanaposhtani M, Moradi A, Nadri H, Mahdavi M, Moghimi S, Asadi M, Firoozpour L, Pirali-Hamedani M, Shafiee A, Foroumadi A.
    Arch Pharm (Weinheim); 2015 Sep 15; 348(9):643-9. PubMed ID: 26192069
    [Abstract] [Full Text] [Related]

  • 32. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Lan JS, Ding Y, Liu Y, Kang P, Hou JW, Zhang XY, Xie SS, Zhang T.
    Eur J Med Chem; 2017 Oct 20; 139():48-59. PubMed ID: 28797883
    [Abstract] [Full Text] [Related]

  • 33. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
    Nerella A, Jeripothula M.
    Bioorg Med Chem Lett; 2021 Oct 01; 49():128212. PubMed ID: 34153471
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
    Mahdavi M, Hariri R, Mirfazli SS, Lotfian H, Rastergari A, Firuzi O, Edraki N, Larijani B, Akbarzadeh T, Saeedi M.
    Chem Biodivers; 2019 Apr 01; 16(4):e1800488. PubMed ID: 30720917
    [Abstract] [Full Text] [Related]

  • 35. Novel 3-benzylidene/benzylphthalide Mannich base derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Cao Z, Song Q, Yu G, Liu Z, Cong S, Tan Z, Deng Y.
    Bioorg Med Chem; 2021 Apr 01; 35():116074. PubMed ID: 33640707
    [Abstract] [Full Text] [Related]

  • 36. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
    Gurjar AS, Darekar MN, Yeong KY, Ooi L.
    Bioorg Med Chem; 2018 May 01; 26(8):1511-1522. PubMed ID: 29429576
    [Abstract] [Full Text] [Related]

  • 37. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
    Zheng Y, Qiang X, Xu R, Song Q, Tian C, Liu H, Li W, Tan Z, Deng Y.
    Bioorg Chem; 2018 Aug 01; 78():298-306. PubMed ID: 29625269
    [Abstract] [Full Text] [Related]

  • 38. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y, Yang H, Huang Z, Tian S, Li Q, Du C, Chen T, Liu Y, Sun H, Liu Z.
    Molecules; 2020 Jan 23; 25(3):. PubMed ID: 31979317
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L, Luo Z, He F, Lu J, Li X.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4475-84. PubMed ID: 20471843
    [Abstract] [Full Text] [Related]

  • 40. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
    Jameel E, Meena P, Maqbool M, Kumar J, Ahmed W, Mumtazuddin S, Tiwari M, Hoda N, Jayaram B.
    Eur J Med Chem; 2017 Aug 18; 136():36-51. PubMed ID: 28478343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.